Abstract
ObjectivesSubcutaneous tumour necrosis factor alpha TNFαinhibitors (SC-TNFis) such as golimumab (GLM), adalimumab (ADA), etanercept (ETA) and certolizumab pegol (CZP) have been used for many years for the treatment of inflammatory...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have